Understanding Low-Dose Naltrexone (LDN) for Thyroid Health

Sarah J. Zielsdorf, MD, MS, ABIM, IFMCP

Learn more about low-dose naltrexone (LDN), an off-label medication that may be considered as part of an individualized approach to autoimmune thyroid disease. This presentation explores LDN’s proposed anti-inflammatory and immune-modulating effects, along with its use in compounded therapy.